Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144
Rhea-AI Filing Summary
IDXX filed a Form 144 reporting a proposed sale of Common Stock through Goldman Sachs & Co. LLC. The filing lists multiple lots of Restricted Stock Units acquired as compensation on 05/11/2022, 05/11/2023, 05/06/2024, 05/06/2025, and 05/07/2026 with indicated share counts.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed insider disposals of Common Stock tied to prior RSU awards.
The filing identifies Goldman Sachs & Co. LLC as the broker and enumerates five RSU acquisition dates with associated share counts (224; 344; 257; 262; 257). These line items are presented as securities to be sold.
Because the excerpt provides discrete grant dates and share counts but no aggregate sale amount or timing, the precise proceeds, net holdings after sale, and whether sales are planned under a trading plan are not shown in the provided text. Subsequent filings or the full Form 144 may disclose execution details.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
Broker-dealer financial
FAQ
What does the IDXX Form 144 filing mean?
Which broker is handling the proposed sales for IDXX?
How many Restricted Stock Unit lots are listed in the filing?
Does the Form 144 show the dollar proceeds or execution timing?
AI-generated analysis. How Rhea-AI works. Not financial advice.